Literature DB >> 16289631

Examples of tropical disease control in the humanitarian medical programmes of MSF and Merlin.

Manica Balasegaram1, Seyoum Dejene, Peter Tinnemann, Samantha Perkins, Robert Davidson.   

Abstract

Humanitarian medical programmes in the tropics have the opportunity to provide beacons of good practice. The use of modern drugs and diagnostics, a lack of bureaucracy, adequate budgets, motivated staff and well-functioning supply lines all contribute to the success of this approach. At a joint meeting of the Royal Society of Tropical Medicine, the London School of Hygiene and Tropical Medicine, Médecins Sans Frontières and Merlin, new data were presented on the outcomes of recent humanitarian programmes to control malaria (Ethiopia), human African trypanosomiasis (south Sudan), Lassa fever (Sierra Leone) and tuberculosis (Tomsk, former USSR).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289631     DOI: 10.1016/j.trstmh.2005.08.010

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Southern Sudan: an opportunity for NTD control and elimination?

Authors:  John Rumunu; Simon Brooker; Adrian Hopkins; Fasil Chane; Paul Emerson; Jan Kolaczinski
Journal:  Trends Parasitol       Date:  2009-06-17

2.  In Search of the 'New Informal Legitimacy' of Médecins Sans Frontières.

Authors:  Philippe Calain
Journal:  Public Health Ethics       Date:  2011-12-30       Impact factor: 1.940

Review 3.  Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?

Authors:  José A Ruiz-Postigo; José R Franco; Mounir Lado; Pere P Simarro
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

4.  A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot.

Authors:  Louise Sigfrid; Catrin Moore; Alex P Salam; Nicola Maayan; Candyce Hamel; Chantelle Garritty; Vittoria Lutje; Brian Buckley; Karla Soares-Weiser; Rachel Marshall; Mike Clarke; Peter Horby
Journal:  BMC Med       Date:  2019-06-11       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.